Sunshine Biopharma Inc.

SBFM · Nasdaq · SIC 2834: Pharmaceutical Preparations
183
SEC Filings

Business Summary

Sunshine Biopharma Inc. is a pharmaceutical company with two Canadian subsidiaries: Nora Pharma Inc., which markets 71 generic prescription drugs in Canada across oncology, cardiovascular, CNS, and other areas, and Sunshine Biopharma Canada Inc., which develops and sells OTC supplements. The company also conducts proprietary drug development including K1.1 mRNA (liver cancer) and SBFM-PL4 (SARS Coronavirus protease inhibitor), both in animal testing stages.

Next Earnings

Q2 FY2026 — expected 2026-09-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionSBFMdiscussed_in_filing Cybersecurity
topic_mentionSBFMdiscussed_in_filing Trusted Computing
topic_mentionSBFMdiscussed_in_filing Blockchain & Crypto
topic_mentionSBFMdiscussed_in_filing Supply Chain
topic_mentionSBFMdiscussed_in_filing Regulation
topic_mentionSBFMdiscussed_in_filing Automotive
topic_mentionSBFMdiscussed_in_filing Healthcare & Bio
topic_mentionSBFMdiscussed_in_filing AI Compute
topic_mentionSBFMdiscussed_in_filing Platform & Ecosystem
topic_mentionSBFMdiscussed_in_filing Sovereign & Government
topic_mentionSBFMdiscussed_in_filing Cybersecurity
topic_mentionSBFMdiscussed_in_filing Trusted Computing
topic_mentionSBFMdiscussed_in_filing Blockchain & Crypto
topic_mentionSBFMdiscussed_in_filing Supply Chain
topic_mentionSBFMdiscussed_in_filing Regulation
topic_mentionSBFMdiscussed_in_filing Automotive
topic_mentionSBFMdiscussed_in_filing Healthcare & Bio
topic_mentionSBFMdiscussed_in_filing AI Compute
topic_mentionSBFMdiscussed_in_filing Platform & Ecosystem
topic_mentionSBFMdiscussed_in_filing Sovereign & Government

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-04-032025-12-310001683168-26-002644EDGAR35K words
2025-04-012024-12-310001683168-25-002184EDGAR—
2024-03-282023-12-310001683168-24-001818EDGAR—
2023-04-042022-12-310001683168-23-002128EDGAR—
2022-03-212021-12-310001683168-22-001788EDGAR—
2021-03-302020-12-310001654954-21-003507EDGAR—
2020-05-012019-12-310001654954-20-004731EDGAR—
2019-04-122018-12-310001654954-19-004354EDGAR—
2018-04-022017-12-310001654954-18-003495EDGAR—
2017-04-172016-12-310001654954-17-003365EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001683168-25-008328EDGAR13K words
2025-08-122025-06-300001683168-25-005981EDGAR—
2025-05-152025-03-310001683168-25-003701EDGAR—
2024-11-052024-09-300001683168-24-007622EDGAR—
2024-08-162024-06-300001683168-24-005846EDGAR—
2024-05-202024-03-310001683168-24-003688EDGAR—
2023-11-132023-09-300001683168-23-007911EDGAR—
2023-08-102023-06-300001683168-23-005518EDGAR—
2023-05-102023-03-310001683168-23-003121EDGAR—
2022-11-072022-09-300001683168-22-007290EDGAR—
2022-08-032022-06-300001683168-22-005298EDGAR—
2022-05-062022-03-310001683168-22-003262EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-090001683168-26-001609EDGAR3K words
2026-02-200001683168-26-001216EDGAR—
2026-02-050001683168-26-000789EDGAR—
2025-12-120001683168-25-009103EDGAR—
2025-09-300001683168-25-007338EDGAR—
2025-05-190001683168-25-003838EDGAR—
2025-04-030001683168-25-002245EDGAR—
2025-04-020001683168-25-002193EDGAR—
2025-01-150001683168-25-000357EDGAR—
2024-12-100001683168-24-008607EDGAR—

183 total filings indexed. 151 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

canadian-generic-pharmaceuticals oncology antiviral-therapeutics otc-supplements gmp-(good-manufacturing-practice) ands-(abbreviated-new-drug-submission) lnp-(lipid-nanoparticle)-delivery-technology pct-(patent-cooperation-treaty)

Company Identity

CIK0001402328
TickerSBFM
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedCO

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 1631f755095db08f19013054ad46b37516aa2ca96f782432e758ab0e2ddea546
parent: 86e41ef2a046e91bfcb7cf29fb838b32e02fe07f0f5126098abdafb37aa741c2
content hash: 103bf788909fd503d97887b649d9bb77ebe9ed69f1a70cc6a253369c3dac9431
signed: 2026-04-13T04:47:19.861Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf